Lv31
230 积分 2024-05-24 加入
Novel recurrence risk stratification of resected pancreatic neuroendocrine tumor
2小时前
待确认
Recurrence and treatment trends of pancreatic neuroendocrine tumors
2小时前
待确认
Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2
2小时前
已完结
Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
22天前
已完结
Associations of Combined Genetic and Lifestyle Risks With Incident Cardiovascular Disease and Diabetes in the UK Biobank Study
1个月前
已完结
The influence of socioeconomic inequity and guidelines compliance on clinical outcomes of patients with acute biliary pancreatitis. An international multicentric cohort study
2个月前
已完结
Early-Onset Pancreatic Neuroendocrine Tumors
2个月前
已完结
Comparative outcomes of pancreatic neuroendocrine neoplasms: A population-based analysis of the SEER database
2个月前
已完结
177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial
2个月前
已完结
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
4个月前
已完结
皖公网安备34019202002308
